Anjela Tzontcheva

Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials

Lorcan McGarvey, Surinder S. Birring, Alyn H. Morice et al. · The Lancet · 2022 · 286 citations

Asthma, Medicine, Clinical Trials +6

A Randomized, Double‐Blind, Placebo‐Controlled, Sixteen‐Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis

Joachim Sieper, Désirée van der Heijde, Maxime Dougados et al. · Arthritis & Rheumatology · 2015 · 218 citations · Full text

The Combination of <i>p53</i> Mutation and <i>neu/erb</i>B-2 Amplification Is Associated With Poor Survival in Node-Negative Breast Cancer

Shelley B. Bull, Hilmi Özçelik, Dushanthi Pinnaduwage et al. · Journal of Clinical Oncology · 2003 · 99 citations · Full text

Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease

Fabrizio Stocchi, Olivier Rascol, Robert A. Hauser et al. · Neurology · 2017 · 63 citations

An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadism

Eberhard Nieschlag, Pierre-Marc Bouloux, Barbara J. Stegmann et al. · Reproductive Biology and Endocrinology · 2017 · 41 citations · Full text